Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin-1 receptor

Zheng, Y; Sang, MX; Liu, F; Gu, LA; Li, J; Wu, YY; Shan, BE

Shan, BE (通讯作者),Hebei Med Univ, Hosp 4, Res Ctr, 12 Jiankang Rd, Shijiazhuang 050017, Hebei, Peoples R China.

ONCOLOGY REPORTS, 2023; 50 (1):

Abstract

Increasing evidence showed that the substance P (SP)/neurokinin-1 receptor (NK1R) complex is involved in the development of several cancers. However, ......

Full Text Link